Marvell Technology's stock has surged 179.33% over the past year driven by strong demand for custom AI chips and expanding roles in hyperscale AI infrastructure. The company reported record Q3 FY2026 revenue of $2.07 billion, with data center sales growing 38% year-over-year. Despite bullish AI growth prospects and collaborations with Nvidia, Alphabet, and Amazon, the stock trades near its 52-week high with a high valuation, leading analysts to recommend a hold with moderate confidence. Future upside depends on continued execution and growth in custom AI silicon revenue, while risks include high valuation, customer concentration, and potential competition from hyperscalers building their own chips.
Nvidia posted an 85% year-over-year revenue increase and raised its full-year 2027 guidance, underscoring its leadership in AI technology development. Despite strong earnings, the stock's price movement suggests investors worry that much of the poten...
Wells Fargo raised its price target for Marvell Technology to $195 from $135, citing AWS Trainium deployment and custom silicon momentum, while Oppenheimer increased its target to $200 from $170 ahead of quarterly results. Both firms highlight Marvel...
Marvell Technology's stock has doubled year-to-date, driven by Nvidia's $2 billion investment and strong future revenue guidance. The company raised its FY2027 revenue forecast to $11 billion, indicating over 30% growth fueled by custom silicon and A...
Marvel Biosciences Corp. awarded 50,001 deferred share units (DSUs) to its three independent directors as payment for their fees, replacing cash payments. These DSUs will vest on May 19, 2027, and will be settled when the directors leave the company....
Marvell Technology's stock surged nearly 97% year-to-date in 2026, driven by strong demand for its AI data center chips and record fiscal 2026 revenue of $8.195 billion, up 42% year-over-year. Several U.S. Congress members, including those on financi...
